Abstract:Objective: To identify individual and systems-focused risk factors for pars plana vitrectomy among patients with proliferative diabetic retinopathy (PDR) in a diverse, urban, safety-net hospital setting. Design: Single-center, retrospective, observational, case-control study at Zuckerberg San Francisco General Hospital and Trauma Center between 2017 and 2022. Subjects: Two hundred twenty-two patients with PDR over a 5-year span (2017-2022), consisting of 111 cases who underwent vitrectomy for vision-threatening complications (tractional retinal detachment, nonclearing vitreous hemorrhage, and neovascular glaucoma) and 111 controls with PDR with no history of vitrectomy or vision-threatening complications. Controls were matched 1:1 through incidence density sampling. Methods: Medical records were reviewed from time of entry into hospital system to vitrectomy date (or date-matched clinic visit for controls). Individual-focused exposures included age, gender, ethnicity, language, homelessness, incarceration, smoking status, area deprivation index, insurance status, baseline retinopathy stage, baseline visual acuity, baseline hemoglobin A1c, panretinal photocoagulation status, and cumulative anti-VEGF treatments. System-focused exposures included external department involvement, referral route, time within hospital and ophthalmology systems, interval between screening and ophthalmology appointment, interval between conversion to proliferative disease and panretinal photocoagulation or first treatment, and loss-to-follow-up in intervals of active proliferative disease. Main outcome measures: Odds ratios (ORs) for each exposure on vision-threatening diabetic complications requiring vitrectomy. Results: The absence of panretinal photocoagulation was the primary significant individual-focused risk factor for vitrectomy in the multivariable analysis (OR, 4.78; P = 0.011). Systems-focused risk factors included longer interval between PDR diagnosis and initial treatment (weeks; OR, 1.06; P = 0.024) and greater cumulative duration of loss-to-follow-up during intervals of active PDR (months; OR, 1.10; P = 0.002). Greater duration in the ophthalmology system was the primary systems-focused protective factor against vitrectomy (years; OR, 0.75; P = 0.035). Conclusions: Largely modifiable variables modulate risk of complications requiring diabetic vitrectomy. Each additional month of loss-to-follow-up for patients with active proliferative disease increased odds of vitrectomy by 10%. Optimizing modifiable factors to promote earlier treatment and maintain critical follow-up in proliferative disease may reduce vision-threatening complications requiring vitrectomy in a safety-net hospital setting. Financial disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Controlling Early Postoperative Elevated Intraocular Pressure: the First Reason Cited for Postoperative Inpatient Hospitalization after Diabetic Vitrectomy

Analysis of Secondary High Intraocular Pressure after Vitreoretinal Surgery for Proliferative Diabetic Retinopathy

Incidence and related factors of intraocular pressure elevation at early stage after pars plana vitrectomy for retinal detachment

Treatment and Observation of Postvitrectomy Diabetic Vitreous Haemorrhage in Patients with PDR

The Clinical Analysis of Intraocular Pressure Elevation after Pars Plana Vitrectomy

Related factors and treatment of high intraocular pressure after PPV with intraocular padding

Clinical analysis of intraocular pressure(IOP) elevation after vitrectomy and silicon oil tamponade

Intraocular Pressure 1 Year after Vitrectomy in Eyes Without a History of Glaucoma or Ocular Hypertension

Perioperative anti-vascular endothelial growth factor agents treatment in patients undergoing vitrectomy for complicated proliferative diabetic retinopathy: a network meta-analysis

Factors related to postoperative vitreous hemorrhage after small-gauge vitrectomy in proliferative diabetic retinopathy patients

Clinical analyses of late vitreous hemorrhage after vitreoretinal surgery in proliferative diabeticretinopathy

Analysis of surgical timing and therapeutic effect of vitrectomy for proliferative diabetic retinopathy combined with vitreous hemorrhage

Different intraocular tamponade during vitrectomy on proliferative diabetic retinopathy

Clinical Analysis of High Intraocular Pressure after Vitreoretinal Surgery

Influential factors of blood glucose during perioperative period for patients with proliferative diabetic retinopathy

The Association Between Different Hypoglycemic Regimens and Postoperative Diabetic Macular Edema after Vitrectomy in the Japanese Patients with Proliferative Diabetic Retinopathy

Individual and Systems-Based Risk Factors for Diabetic Vitrectomy in an Urban Safety-Net Hospital

Clinical Analysis of 102 Cases of Proliferative Diabetic Retinopathy with Surgical Treatment

Retrospective Analysis of Surgical Treatments in 128 Patients with Proliferative Diabetic Retinopathy Combined with Vitreous Hemorrhage

Preoperative and intraoperative adjunctive intravitreal conbercept in 23G vitrectomy for proliferative diabetic retinopathy

A Relatively Higher Intraocular Pressure Set at the End of Vitrectomy is Associated with a More Stable and Rapid Visual Recovery for Patients with Vitreous Haemorrhage